Samuel Jiménez Sánchez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Samuel Jiménez Sánchez has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Celia Sánchez Gómez
Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain
1 shared publication - Eduardo José Fernández-Rodríguez
Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain
1 shared publication - Emilio Fonseca-Sánchez
Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain
1 shared publication - Juan Luis Sánchez-González
Department of Nursing and Physiotherapy, Universidad de Salamanca, 37007 Salamanca, Spain
1 shared publication - María Isabel Rihuete Galve
Department of Nursing and Physiotherapy, Universidad de Salamanca, 37008 Salamanca, Spain
1 shared publication - Sara Jiménez García-Tizón
Department of Developmental and Educational Psychology, University of Salamanca, Salamanca, Spain
1 shared publication
Latest Publications
- Open Access
- 16 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5047
A Cognitive Training Programme on Cancer-Related Cognitive Impairment (CRCI) in Breast Cancer Patients Undergoing Active Treatment: A RCT Study Protocol
Background: In light of increasing breast cancer survival rates, it is essential to address cancer-related cognitive impairment (CRCI), a common yet often underestimated symptom. Methods: A randomised controlled trial is proposed involving 50 newly diagnosed participants, divided into a control group (CG) and an intervention group (IG). Both groups will receive an educational leaflet, while the IG will also take part in an individualised cognitive training programme based on everyday cognition (80 sessions distributed across four periods, compiled in a training dossier). Cognitive, emotional, and functional variables will be assessed before and after the intervention: cognitive function (MoCA test), everyday cognition (PECC), anxiety (Hamilton), functionality (LB), sleep quality (PSQI), quality of life (ECOG), and subjective memory complaints (FACT-COG). Expected results: Findings may guide future interventions and tailored protocols to alleviate CRCI in breast cancer patients undergoing active treatment. Ethics and dissemination: This study was approved by the Ethics Committee of the University of Salamanca (PI 2023 12 1478-TD).
- 16 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5047
Open AccessA Cognitive Training Programme on Cancer-Related Cognitive Impairment (CRCI) in Breast Cancer Patients Undergoing Active Treatment: A RCT Study Protocol
Background: In light of increasing breast cancer survival rates, it is essential to address cancer-related cognitive impairment (CRCI), a common yet often underestimated symptom. Methods: A randomised controlled trial is proposed involving 50 newly diagnosed participants, divided into a control group (CG) and an intervention group (IG). Both groups will receive an educational leaflet, while the IG will also take part in an individualised cognitive training programme based on everyday cognition (80 sessions distributed across four periods, compiled in a training dossier). Cognitive, emotional, and functional variables will be assessed before and after the intervention: cognitive function (MoCA test), everyday cognition (PECC), anxiety (Hamilton), functionality (LB), sleep quality (PSQI), quality of life (ECOG), and subjective memory complaints (FACT-COG). Expected results: Findings may guide future interventions and tailored protocols to alleviate CRCI in breast cancer patients undergoing active treatment. Ethics and dissemination: This study was approved by the Ethics Committee of the University of Salamanca (PI 2023 12 1478-TD).